Grifols is trading at $8.46, up 4.44%, amid broader U.S. market gains.
- No company-specific announcement explaining the November 2 move was identified.
- Grifols was scheduled to report third-quarter results after the Spanish market close; results were not yet available at 11:45 a.m. EST.
- The S&P 500, Nasdaq and Dow were each up more than 0.5%, while the biotech sector was down.